The effect of high-dose enteral glutamine on the incidence and severity of mucositis in paediatric oncology patients

European Journal of Clinical Nutrition

Volumn 63, Issue 1, 2009, Pages 134-140

  Ward, E ^a   Smith, M ^a   Henderson, M ^a   Reid, U ^b   Lewis, I ^b   Kinsey, S ^b   Allgar, V ^c   Bowers, D ^c   Picton, S V ^b  

^a ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

^b Yorkshire Regional Centre for Paediatric Oncology and Haematology   (United Kingdom)

^c UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMMONIA; ANTINEOPLASTIC AGENT; GLUTAMINE;

ABDOMINAL PAIN; ABSENCE OF SIDE EFFECTS; ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ADULT; AMMONIA BLOOD LEVEL; ARTICLE; B CELL LYMPHOMA; CHEMOTHERAPY INDUCED EMESIS; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DISEASE SEVERITY; DRUG EFFICACY; DRUG MEGADOSE; ENTERIC FEEDING; EWING SARCOMA; FEMALE; HUMAN; MALE; MUCOSA INFLAMMATION; MULTIPLE CYCLE TREATMENT; NAUSEA; NEUROECTODERM TUMOR; NONHODGKIN LYMPHOMA; OSTEOSARCOMA; PARENTERAL NUTRITION; RANDOMIZED CONTROLLED TRIAL; RHABDOMYOSARCOMA; SOLID TUMOR; STOMATITIS; TREATMENT DURATION; UNITED KINGDOM;

ADMINISTRATION, ORAL; ADOLESCENT; AMMONIA; ANTINEOPLASTIC AGENTS; CHILD; CHILD, PRESCHOOL; ENTERAL NUTRITION; FEMALE; GASTROINTESTINAL TRACT; GLUTAMINE; HUMANS; MALE; MUCOSITIS; NEOPLASMS; PARENTERAL NUTRITION; YOUNG ADULT;

EID: 58149477874     PISSN: 09543007     EISSN: 14765640     Source Type: Journal    
DOI: 10.1038/sj.ejcn.1602894     Document Type: Article

References (26)

1. Anderson PM, Schroeder G, Skubitz KM (1998). Oral glutamine reduces the duration and severity of stomatitis after cytotoxic cancer chemotherapy. Cancer 83, 1433-1439.
2. Aquino VM, Harvey AR, Garvin JH, Godder KT, Nieder ML, Adams RH et al. (2005). A double-blind randomised placebo-controlled study of oral glutamine in the prevention of mucositis in children undergoing haematopoietic stem cell transplantation: A paediatric blood and marrow transplant consortium study. Bone Marrow Transplant 36, 611-616.
3. Buchman AL (1996). Glutamine: Is it a conditionally required nutrient for the human gastrointestinal system? J Am Coll Nutr 15, 199-205.
4. Buchman AL, Moukarzel AA, Bhuta S, Belle M, Ament ME, Eckhert CD et al. (1995). Parenteral nutrition is associated with intestinal morphologic and functional changes in humans. J Parenter Enteral Nutr 19, 453-460.
5. Cockerham MB, Weinberger BB, Lerchie SB (2000). Oral glutamine for the prevention of oral mucositis associated with high-dose Paclitaxel and Melphalan for autologous bone marrow transplantation. Ann Pharmacother 34, 300-303.
6. Duncan M, Grant G (2003). Review article: Oral and intestinal mucositis - causes and possible treatments. Aliment Pharmacol Ther 18, 853-874.
7. Gardiner KR, Kirk SJ, Rowlands BJ (1995). Novel substrates to maintain gut integrity. Nutr Res Rev 8, 43-64.
8. Green A (1988). When and how should we measure plasma ammonia. Ann Clin Biochem 25, 199-209.
9. Guedon C, Schmitz J, Lerebours E, Metayer J, Audran E, Hemet J et al. (1986). Decreased brush border hydrolase activities without gross morphologic changes in human intestinal mucosa after prolonged total parenteral nutrition of adults. Gastroenterology 90, 373-378.
10. Hall JC, Heel K, McCauley R (1996). Glutamine. Br J Surg 83, 305-312.
11. Jebb SA, Marcus R, Elia M (1995). A pilot study of oral glutamine supplementation in patients receiving bone marrow transplant. Clin Nutr 14, 162-165.
12. Lacey JM, Wilmore DW (1990). Is glutamine a conditionally essential amino acid? Nutr Rev 48, 297-309.
13. Lind MJ (1995). Cytotoxic chemotherapy. Medicine 422-426.
14. Miller AL (1999). Therapeutic considerations of L-glutamine: A review of literature. Altern Med Rev 4, 239-248.
15. Muscaritoli M, Micozzi A, Conversano L, Martino P, Petti MC, Cartoni C et al. (1997). Oral glutamine in the prevention of chemotherapy-induced gastrointestinal toxicity. Eur J Cancer 33 319-320.
16. Peterson DE, Jones JB, Petit II RG (2007). Randomised, placebo-controlled trial of Saforis for the prevention and treatment of oral mucositis in breast cancer patients receiving anthrocycline-based chemotherapy. Cancer 109, 322-331.
17. Petit R, Shinal E, French C (2000). AES-14 facilitates rapid intracellular transport of high levels of L-glutamine in mucosal epithelial cells. Proc Am Soc Clin Oncol 19, 612a (Abstract 2410).
18. Rhoads M (1999). Glutamine signalling in intestinal cells. J Parenter Enteral Nutr 23 (5 Suppl), S38-S40.
19. Savarese DMF, Savy G, Vahdat L, Wischmeyer PE, Corey B (2003). Prevention of chemotherapy and radiation toxicity with glutamine. Cancer Treat Rev 29, 501-513.
20. Schloerb PR, Skikne BS (1999). Oral and parenteral glutamine in bone marrow transplantation: A randomised, double blind study. J Parenter Enteral Nutr 23, 117-122.
21. Skubitz KM, Anderson PM (1996). Oral glutamine to prevent chemotherapy induced stomatitis; a pilot study. J Lab Clin Med 127, 223-228.
22. van Acker BAC, von Meyenfeldt MF, van der Hulst RRWJ, Hulsewe KWE, Wagenmakers AJM, Deutz NEP et al. (1999). Glutamine: The pivot of our nitrogen economy? J Parenter Enteral Nutr 23, S45-S48.
23. van Zaanen HCT, van der Lelie H, Trimmer JG, Frust P, Sauerwein HP (1994). Parenteral glutamine dipeptide supplementation does not ameliorate chemotherapy induced toxicity. Cancer 74, 2879-2884.
24. Ward E, Picton S, Reid U, Thomas D, Gardener C, Smith M et al. (2003). Oral glutamine in paediatric oncology patients: A dose finding study. Eur J Clin Nutr 56, 1-6.
25. Ziegler TR, Benfell K, Smith RJ, Young LS, Brown E, Ferrari-Baliviera E et al. (1990). Safety and metabolic effects of L-glutamine administration in humans. J Parenter Enteral Nutr 14, 137S-146S.
26. Ziegler TR, Young LS, Benfell K, Scheltinga M, Hortos K, Bye R et al. (1992). Clinical and metabolic efficacy of glutamine supplemented parenteral nutrition after bone marrow transplantation. Ann Int Med 116, 821-828.